Stock listing

TPEx:6621 Unipharma Co., Ltd. (華宇藥) 股價

Follow Unipharma Co., Ltd. into a list and get an email when it puts out news.

Share price · TPEX:6621

$10.95 TWD -1.10 (-9.1%)

Close on Nov 20, 2026

This year -9.9% · daily closes, Dec 1, 2025 – Nov 20, 2026, adjusted for splits
Day range
$10.20 – $10.95 TWDNov 20, 2026
Volume
95,430 sharesNov 20, 2026
Market cap
$388.7M TWDAt the close on Nov 20, 2026 · price × 35.50M shares outstanding
Traded on an average day
$651,667 TWDMedian day 40,066 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Unipharma Co., Ltd. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TPEX:6621 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$10.95-1.10-9.1%$10.90$10.95$10.2095,430
$12.05-0.10-0.8%$12.15$12.15$12.0033,010
$12.15+0.15+1.3%$12.20$12.20$11.856,021
$12.00-0.30-2.4%$12.05$12.45$11.9555,018
$12.30-0.15-1.2%$12.45$12.50$12.0561,015
$12.45+0.45+3.7%$12.20$12.45$11.9535,010
$12.00-0.15-1.2%$12.25$12.25$11.9570,008
$12.15-0.05-0.4%$12.20$12.25$12.1512,908
$12.20+0.20+1.7%$11.85$12.20$11.851,104
$12.00-0.65-5.1%$12.25$12.25$11.6560,528
$12.65+0.30+2.4%$12.50$12.65$12.2037,739
$12.35-0.15-1.2%$12.55$12.55$12.2570,104
$12.50+0.05+0.4%$12.55$12.70$12.3565,016
$12.45-0.15-1.2%$12.70$12.70$12.4526,069
$12.60+0.15+1.2%$12.45$12.65$12.25182,511
$12.45-0.10-0.8%$12.65$12.65$12.30193,619
$12.55+0.50+4.1%$12.05$12.65$11.95148,086
$12.05+0.50+4.3%$11.55$12.05$11.5099,674
$11.550.000.0%$11.55$11.55$11.550
$11.55+0.50+4.5%$11.05$11.55$11.0077,739
$11.05-0.25-2.2%$11.55$11.55$11.0523,114
$11.30-0.55-4.6%$11.50$11.70$10.50178,219
$11.85-0.05-0.4%$11.90$11.90$11.5029,319
$11.90-0.20-1.7%$12.10$12.10$11.5019,713
$12.10+0.10+0.8%$12.05$12.10$11.707,009
$12.00-0.20-1.6%$12.05$12.20$11.6036,307
$12.200.000.0%$12.05$12.60$12.0522,225
$12.20-0.40-3.2%$12.65$12.65$12.0522,029
$12.60+0.40+3.3%$12.60$12.60$12.206,097
$12.20-0.30-2.4%$12.65$12.65$12.1533,415
$12.50+0.20+1.6%$12.50$12.50$12.1072,016
$12.30-0.10-0.8%$12.55$12.55$11.9555,129
$12.40+0.05+0.4%$12.35$12.40$11.959,031
$12.35-0.20-1.6%$12.55$12.55$12.2054,008
$12.55-0.05-0.4%$12.60$12.60$12.35143,336
$12.60+0.70+5.9%$12.05$12.60$12.05158,048
$11.90-0.05-0.4%$12.10$12.10$11.80114,825
$11.95+0.40+3.5%$11.85$11.95$11.6572,368
$11.55+0.05+0.4%$11.80$11.85$11.5030,559
$11.50+0.10+0.9%$11.60$11.60$11.4540,008
$11.400.000.0%$11.60$11.60$11.3056,113
$11.40-0.15-1.3%$11.15$11.50$11.1595,011
$11.55+0.05+0.4%$11.50$11.55$11.1521,318
$11.500.000.0%$11.50$11.50$11.208,009
$11.50-0.05-0.4%$11.30$11.50$11.2040,124
$11.55-0.05-0.4%$11.20$11.55$11.2010,171
$11.600.000.0%$11.60$11.65$11.2037,007
$11.60+0.40+3.6%$11.45$11.60$11.2064,542
$11.20-0.25-2.2%$11.15$11.70$11.1552,018
$11.45+0.25+2.2%$11.15$11.45$11.1076,066
$11.20-0.25-2.2%$11.45$11.45$10.9550,806
$11.45+0.15+1.3%$11.45$11.45$11.002,012
$11.300.000.0%$10.95$11.30$10.9521,004
$11.30-0.05-0.4%$11.45$11.45$10.9029,015
$11.35-0.10-0.9%$11.45$11.45$11.1063,018
$11.45+0.35+3.2%$11.15$11.50$11.1030,508
$11.100.000.0%$11.55$11.55$11.0541,229
$11.10-0.40-3.5%$11.55$11.55$11.1098,313
$11.500.000.0%$11.55$11.55$11.1515,009
$11.50-0.05-0.4%$11.60$11.60$11.152,018
$11.550.000.0%$11.55$11.55$11.0080,033
$11.55-0.10-0.9%$11.65$11.65$11.1535,114
Ticker
TPEx:6621
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
TPEx
Currency
TWD

Latest news

All Unipharma Co., Ltd. news

Unipharma Co., Ltd. on 6ix

Sector
Health care
Industry
Health care services
News releases
1 in the last 12 months · 1 in all · newest Feb 12, 2026 · oldest 2026

Valuation

EV/sales 3.2× against a median of 1.1×: 8th lowest of 11 Health care services companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$281.1M TWD
P/E
Loss
EV/sales
3.2×
EV/EBITDA
Negative EBITDA
Price/book
2.0×
Gross margin
53.4%
Operating margin
−49.9%
Net margin
−45.8%
Debt to equity
0.0×
Beta
No index for this market yet

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Unipharma Co., Ltd. · TPEX:6621US$11.79MUS$8.53Mn/a3.2×n/a2.0×−45.8%0.0×n/a
Beamtree Holdings Ltd · ASX:BMTUS$12.71MUS$13.72Mn/a0.7×149×0.8×−62.6%0.2×n/a
Genesis Fertility Center Public Company Limited · SET:GFCUS$12.70MUS$9.80M19.3×0.9×4.0×0.8×6.3%0.0×n/a
Talius Group Limited · ASX:TALUS$12.55MUS$9.78Mn/a1.9×n/a3.1×−19.1%0.1×n/a
Mukdahan International Hospital Public Company Limited · SET:HANNUS$12.20MUS$9.07M66.8×0.7×6.3×1.4×1.4%0.1×n/a
Alzai Health Corp. · TSXV:ALZIUS$11.86MUS$10.93Mn/a227×n/a11.2×n/a0.4×n/a
Eukedos SpA · MIL:EUKUS$11.73MUS$11.27Mn/a0.2×1.2×0.4×−1.4%0.0×n/a
ImExHS Ltd · ASX:IMEUS$11.16MUS$10.15Mn/a0.5×10.1×1.0×−10.0%0.0×n/a
Intrasense SA · EURONEXT:ALINSUS$11.00MUS$10.61Mn/a3.3×n/an/a−364.8%n/an/a
iTonic Holdings Ltd · NASDAQ:ITOCUS$10.87MUS$8.90Mn/a17.0×n/a0.5×−974.7%0.0×1.06
Republic Healthcare Limited · HKEX:8357US$10.83MUS$9.29Mn/a1.2×n/a1.8×−40.3%0.4×n/a
Median of the othersUS$11.79MUS$9.98M43.0×1.1×6.3×1.0×−19.1%0.1×1.06

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue88.4M93.5M103.2M128.1M105.4M138.6M154.3M
Cost of revenue41.2M44.7M52.2M53.5M46.1M69.3M80.5M
Gross profit47.2M48.7M51.0M74.6M59.3M69.3M73.8M
Research and development22.8M16.6M17.8M26.3M33.0M24.9M34.8M
Selling, general and administrative68.5M22.8M19.9M20.3M30.3M22.0M20.2M
Operating income-44.1M-30.8M-27.3M-20.9M-40.2M-20.6M-27.8M
Depreciation and amortization7.00M7.00M5.54M5.53M10.8M11.2M11.1M
EBITDA-37.1M-23.8M-21.8M-15.3M-29.4M-9.44M-16.7M
Interest expense99.0K108.0K14.0K39.0K99.0K141.0K163.0K
Income before tax-40.5M-24.8M-21.8M-7.03M-74.4M-55.4M-25.0M
Net income-40.5M-24.8M-21.8M-6.45M-74.4M-55.4M-25.0M
Earnings per share, basic-1.14-0.70-0.61-0.18-2.11-1.57-0.71

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents29.0M58.7M68.6M63.8M76.0M74.6M200.5M
Short-term investments106.4M98.5M98.5M98.5M99.5M113.5M
Receivables14.7M16.9M21.2M34.1M23.0M24.2M25.3M
Inventory31.3M22.3M28.9M31.0M35.9M25.7M26.0M
Current assets184.5M200.0M226.2M238.3M261.4M241.4M256.3M
Total assets275.0M329.0M350.1M332.6M348.2M415.6M456.1M
Accounts payable18.0M14.5M22.2M6.09M27.7M2.22M10.5M
Current liabilities37.9M33.2M37.1M28.8M46.8M25.1M37.9M
Total debt14.8M277.0K3.53M6.99M16.8M22.4M
Total liabilities45.2M44.2M37.4M29.3M50.6M36.6M54.9M
Shareholders' equity229.8M284.8M312.7M303.2M297.6M379.0M401.2M
Shares outstanding35.5M35.5M35.5M35.5M35.2M35.2M35.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-36.7M-14.3M12.0M-31.7M-12.9M-17.2M-9.24M
Capital spending-1.88M-2.84M-8.11M-435.0K-3.21M-638.0K-283.0K
Free cash flow-38.6M-17.2M3.92M-32.1M-16.1M-17.8M-9.52M
Cash from investing8.18M-3.89M-1.12M19.8M31.9M1.93M
Cash from financing-3.83M-3.26M20.6M-5.49M-5.57M-8.13M
Share buybacks-2.76M
Change in cash-29.7M-9.97M4.89M-12.2M1.37M9.11M-15.4M

Open Financials

Cap table

Built by 6ix from Unipharma Co., Ltd.’s releases

Common shares
35,501,000
Fully diluted
35,501,000

Fully diluted

LineShares
Common shares35,501,000

Share count over time

CountShares
Nov 22, 202635,501,000

Open Cap table

Shareholders

HolderSharesOf the companyAs of
健亞生物科技股份有限公司6.27M17.7%Oct 31, 2026
鄭明聰982K2.8%Oct 31, 2026
陳正540K1.5%Oct 31, 2026
戴國明468K1.3%Oct 31, 2026
蘇志宏388K1.1%Oct 31, 2026
王愈善60,0000.17%Oct 31, 2026
邱明善33,0000.09%Oct 31, 2026
鄭巧蕾10,0000.03%Oct 31, 2026
馬銘襌00.00%Oct 31, 2026
李俊德00.00%Oct 31, 2026
All 13 holders
HolderSharesOf the companyAs of
陳建文00.00%Oct 31, 2026
簡合瑩00.00%Oct 31, 2026
鄭宏泰00.00%Oct 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Unipharma Co., Ltd.